TrendFlares logo

Cardiff Oncology, Inc. (CRDF)

$2.66 7.93% $0.20 Healthcare

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

$123.59M

Dr. Mark Erlander Ph.D.

22.00

San Diego, CA

Jul 27, 2004

-2.89

$-0.92

2.04

4.97

-6,143.91%

-2.79

-0.14

2.17

177.80

4.97

-61.86%

-62.65%

Downtrend

Similar stocks (16)

Day One Biopharmaceuticals, Inc.

DAWN

$14.16 2.68%
Downtrend

Cullinan Oncology, Inc.

CGEM

$17.56 1.89%
Downtrend

Kodiak Sciences Inc.

KOD

$2.63 -1.13%
Downtrend

PDS Biotechnology Corporation

PDSB

$3.22 4.89%
Downtrend

SELLAS Life Sciences Group, Inc.

SLS

$1.26 3.69%
Uptrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.44 4.28%
Downtrend

Lantern Pharma Inc.

LTRN

$4.26 8.95%
Downtrend

Eyenovia, Inc.

EYEN

$0.50 0.96%
Downtrend

Cue Biopharma, Inc.

CUE

$0.56 1.59%
Downtrend

Cognition Therapeutics, Inc.

CGTX

$0.59 -0.77%
Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.62 -0.08%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 3.22%
Downtrend

IN8bio, Inc.

INAB

$0.33 0.30%
Downtrend

TransCode Therapeutics, Inc.

RNAZ

$0.39 11.57%
Downtrend

eFFECTOR Therapeutics, Inc.

EFTR

$0.04 12.50%
Downtrend

ETF Exposure (23)

iShares Micro-Cap ETF

IWC

0.02295%

$126.54 2.19%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00425%

$170.08 1.65%
Uptrend

iShares Russell 2000 ETF

IWM

0.00321%

$223.70 1.94%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00272%

$285.97 2.25%
Uptrend

ProShares Ultra Russell2000

UWM

0.001281706159846007%

$43.91 3.83%
Uptrend

ProShares UltraPro Russell2000

URTY

6.324745032916776e-4%

$53.98 5.67%
Uptrend

ProShares Hedge Replication ETF

HDG

5.395532608146177e-4%

$50.00 0.40%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

4.981899999999999e-4%

$64.93 1.86%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

5.525e-5%

$34.16 1.86%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.16 1.89%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.50 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0%

$207.70 1.97%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0%

$90.46 1.94%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0%

$149.76 1.55%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$183.01 2.05%
Uptrend